Regulation of SsrA-mediated proteolysis of S. aureus

SsrA 介导的金黄色葡萄球菌蛋白水解的调节

基本信息

  • 批准号:
    9089861
  • 负责人:
  • 金额:
    $ 24.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-06-15 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Proteolytic regulation of the SsrA degradation motif in the human pathogen Staphylococcus aureus occurs through a seemingly unique pathway as compared to other prokaryotes. In most cases, the ATP- dependent protease ClpP recognizes and degrades SsrA-tagged proteins following recognition by either the chaperone ClpX or ClpA. S. aureus instead uses the chaperone ClpC and the adaptor TrfA to assist ClpP in SsrA degradation. This novel mechanism is further enhanced by the observation that SsrA breakdown continues to occur during thiol or oxidative stress in strains lacking TrfA, suggesting an additional layer of proteolytic regulation beyond ClpPC/TrfA. To fully characterize the regulation of SsrA-tagged protein levels in S. aureus, our first aim is to uncover additional regulators and adaptors of the SsrA degradation motif in S. aureus and determine their interplay with the known SsrA regulator TrfA. A sequence-defined transposon mutant library of S. aureus USA300 LAC JE2 will be transformed with a plasmid capable of expressing the rapidly maturing Venus protein that is C-terminally tagged with SsrA. To cast the widest net in this search, fluorescence patterns from strains exposed to a variety of stress conditions (e.g. diamide, starvation, etc.) will be obtained. Most strains in these populations will demonstrate low levels o fluorescence due to their persistent degradation of SsrA- tagged Venus. However, a small number will have mutations that affect SsrA degradation, which when compared to patterns from strains lacking clpC or trfA, will allow initial categorization into various control pathways. Subsequent strains doubly disrupted for each candidate gene and trfA will be created to further guide this process, as well as downstream complementation with each identified gene to hone a hierarchy of SsrA regulation in S. aureus. The use of ClpPC/TrfA in S. aureus as mediators of SsrA proteolysis suggests that the established motifs in SsrA used by other microbes may not be valid for S. aureus. Therefore, the S. aureus SsrA sequence may contain novel degradation signals, and our second aim will be to identify novel motifs in the SsrA tag, and to evaluate the importance of various residues in these motifs. Individual and groups of the eleven amino acids of SsrA appended to Venus will be altered to identify critical regions for proteolytic regulation. The resulting changes will be evaluated by monitoring fluorescence over time and during exposure to various stresses. Ultimately, unraveling how S. aureus regulates SsrA-tagged proteins provides an opportunity to better understand how this bacteria adjusts its proteome to challenging environments, and can provide S. aureus- specific targets for treating infections.
 描述(由申请人提供):与其他原核生物相比,人类病原体金黄色葡萄球菌中SsrA降解基序的蛋白水解调节通过看似独特的途径发生。在大多数情况下,ATP依赖性蛋白酶ClpP在被伴侣ClpX或ClpA识别后识别并降解SsrA标记的蛋白质。S.相反,金黄色葡萄球菌使用伴侣ClpC和衔接子TrfA来协助ClpP降解SsrA。通过观察到SsrA分解在缺乏TrfA的菌株中在硫醇或氧化应激期间继续发生,进一步增强了这种新的机制,这表明除了ClpPC/TrfA之外还有另外一层蛋白水解调节。 为了充分表征SsrA标签蛋白在S.金黄色葡萄球菌,我们的第一个目标是发现更多的监管机构和衔接的SsrA降解基序在S。金黄色葡萄球菌,并确定它们与已知的SsrA调节剂TrfA的相互作用。构建了一个序列确定的S.金黄色葡萄球菌USA 300 LAC JE 2将用能够表达C-末端用SsrA标记的快速成熟Venus蛋白的质粒转化。为了在该搜索中撒下最广的网,来自暴露于各种应激条件(例如,二酰胺、饥饿等)的菌株的荧光模式被用于检测细胞的荧光。将获得。这些群体中的大多数菌株由于它们对SsrA标记的Venus的持续降解而将表现出低水平的荧光。然而,少数将具有影响SsrA降解的突变,当与缺乏clpC或trfA的菌株的模式相比时,将允许初始分类为各种控制途径。 随后将创建针对每个候选基因和trfA双重破坏的菌株,以进一步指导这一过程,以及与每个鉴定的基因的下游互补,以磨练S.金黄色。 ClpPC/TrfA在S.金黄色葡萄球菌作为SsrA蛋白水解的介质表明,其他微生物使用的SsrA中已建立的基序可能对S.金黄色。因此,S.金黄色葡萄球菌SsrA序列可能包含新的降解信号,我们的第二个目标将是确定新的基序中的SsrA标签,并评估在这些基序中的各种残基的重要性。将改变附加到Venus的SsrA的11个氨基酸的个体和组,以确定蛋白水解调节的关键区域。将通过监测荧光随时间的变化和暴露于各种应力期间的变化来评价所产生的变化。 最终,解开S。金黄色葡萄球菌调节SsrA标记的蛋白质提供了一个机会,以更好地了解这种细菌如何调整其蛋白质组,以挑战性的环境,并可以提供S。金黄色葡萄球菌-治疗感染的特异性靶点。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ambrose Lin Yau Cheung其他文献

Ambrose Lin Yau Cheung的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ambrose Lin Yau Cheung', 18)}}的其他基金

Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
针对革兰氏阳性病原体的膜活性喹啉和喹唑啉抗菌剂
  • 批准号:
    9973439
  • 财政年份:
    2020
  • 资助金额:
    $ 24.3万
  • 项目类别:
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
针对革兰氏阳性病原体的膜活性喹啉和喹唑啉抗菌剂
  • 批准号:
    10563142
  • 财政年份:
    2020
  • 资助金额:
    $ 24.3万
  • 项目类别:
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
针对革兰氏阳性病原体的膜活性喹啉和喹唑啉抗菌剂
  • 批准号:
    10331864
  • 财政年份:
    2020
  • 资助金额:
    $ 24.3万
  • 项目类别:
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
针对革兰氏阳性病原体的膜活性喹啉和喹唑啉抗菌剂
  • 批准号:
    10117071
  • 财政年份:
    2020
  • 资助金额:
    $ 24.3万
  • 项目类别:
Optimization of a novel compound that enhances the activity of beta-lactams against Gram+ bacteria
增强 β-内酰胺抗革兰氏菌活性的新型化合物的优化
  • 批准号:
    9296686
  • 财政年份:
    2017
  • 资助金额:
    $ 24.3万
  • 项目类别:
Bypassing the restriction barrier to improve transformation in S. epidermidis
绕过限制性屏障以改善表皮葡萄球菌的转化
  • 批准号:
    9386188
  • 财政年份:
    2017
  • 资助金额:
    $ 24.3万
  • 项目类别:
Regulation of SsrA-mediated proteolysis of S. aureus
SsrA 介导的金黄色葡萄球菌蛋白水解的调节
  • 批准号:
    8951755
  • 财政年份:
    2015
  • 资助金额:
    $ 24.3万
  • 项目类别:
The role of CshA and CshB in selective mRNA protection in S. aureus
CshA 和 CshB 在金黄色葡萄球菌选择性 mRNA 保护中的作用
  • 批准号:
    8665389
  • 财政年份:
    2013
  • 资助金额:
    $ 24.3万
  • 项目类别:
The role of CshA and CshB in selective mRNA protection in S. aureus
CshA 和 CshB 在金黄色葡萄球菌选择性 mRNA 保护中的作用
  • 批准号:
    8830428
  • 财政年份:
    2013
  • 资助金额:
    $ 24.3万
  • 项目类别:
The role of CshA and CshB in selective mRNA protection in S. aureus
CshA 和 CshB 在金黄色葡萄球菌选择性 mRNA 保护中的作用
  • 批准号:
    8557227
  • 财政年份:
    2013
  • 资助金额:
    $ 24.3万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 24.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了